JP2021534160A5 - - Google Patents
Info
- Publication number
- JP2021534160A5 JP2021534160A5 JP2021507740A JP2021507740A JP2021534160A5 JP 2021534160 A5 JP2021534160 A5 JP 2021534160A5 JP 2021507740 A JP2021507740 A JP 2021507740A JP 2021507740 A JP2021507740 A JP 2021507740A JP 2021534160 A5 JP2021534160 A5 JP 2021534160A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- riluzole
- vas
- reduces
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023179961A JP2024010017A (ja) | 2018-08-16 | 2023-10-19 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862764864P | 2018-08-16 | 2018-08-16 | |
| US62/764,864 | 2018-08-16 | ||
| PCT/US2019/046709 WO2020037152A1 (en) | 2018-08-16 | 2019-08-15 | Use of riluzole oral disintigrating tablets for treating diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179961A Division JP2024010017A (ja) | 2018-08-16 | 2023-10-19 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534160A JP2021534160A (ja) | 2021-12-09 |
| JP2021534160A5 true JP2021534160A5 (https=) | 2022-03-02 |
Family
ID=69525906
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507740A Pending JP2021534160A (ja) | 2018-08-16 | 2019-08-15 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
| JP2023179961A Pending JP2024010017A (ja) | 2018-08-16 | 2023-10-19 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179961A Pending JP2024010017A (ja) | 2018-08-16 | 2023-10-19 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210315865A1 (https=) |
| EP (1) | EP3836922B1 (https=) |
| JP (2) | JP2021534160A (https=) |
| KR (1) | KR20210045423A (https=) |
| CN (1) | CN112584831A (https=) |
| AU (1) | AU2019322889A1 (https=) |
| BR (1) | BR112021002692A2 (https=) |
| CA (1) | CA3109769A1 (https=) |
| EA (1) | EA202190544A1 (https=) |
| ES (1) | ES2987802T3 (https=) |
| IL (1) | IL280657A (https=) |
| MX (2) | MX2021001563A (https=) |
| PH (1) | PH12021550218A1 (https=) |
| SG (1) | SG11202100880VA (https=) |
| WO (1) | WO2020037152A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7805969B2 (ja) * | 2020-06-24 | 2026-01-26 | バイオヘイブン・セラピューティクス・リミテッド | 強迫性障害を治療するための組成物及び方法 |
| US20240016783A1 (en) * | 2020-10-05 | 2024-01-18 | Icahn School Of Medicine At Mount Sinai | Riluzole for the treatment of alzheimer's disease |
| WO2022103639A1 (en) | 2020-11-16 | 2022-05-19 | Orcosa Inc. | Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| CN114177153B (zh) * | 2021-12-20 | 2023-04-07 | 平顶山市第二人民医院 | 一种利鲁唑口崩片及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
| WO2004047793A1 (en) * | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
| US9241902B2 (en) * | 2003-12-17 | 2016-01-26 | R.P. Scherer Technologies, Llc | Chewable soft capsules containing ungelatinized starch |
| ES2564187T3 (es) * | 2005-04-05 | 2016-03-18 | Yale University | Agentes de modulación de glutamato en el tratamiento de trastornos mentales |
| US20080260823A1 (en) * | 2007-04-20 | 2008-10-23 | Sciele Pharma, Inc. | Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea |
| WO2011019375A1 (en) * | 2009-08-10 | 2011-02-17 | Teva Pharmaceutical Industries Ltd. | Treatment of bdnf-related disorders using laquinimod |
| US9041556B2 (en) | 2011-10-20 | 2015-05-26 | Apple Inc. | Method for locating a vehicle |
| US9434704B2 (en) * | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
| CN107735077A (zh) * | 2014-11-21 | 2018-02-23 | 拜尔哈文制药股份有限公司 | 利鲁唑的舌下给药 |
| WO2016081472A1 (en) * | 2014-11-21 | 2016-05-26 | Biohaven Pharmaceutical Holding Company Ltd. | Sublingual formulation of riluzole |
| KR102462638B1 (ko) * | 2014-11-26 | 2022-11-03 | 메디시노바, 인크. | 이부딜라스트와 릴루졸의 배합물 및 이의 사용방법 |
| WO2016140879A1 (en) * | 2015-03-03 | 2016-09-09 | Biohaven Pharmaceutical Holding Company Ltd. | Riluzole prodrugs and their use |
| AU2018215056A1 (en) * | 2017-01-31 | 2019-08-08 | Charles E. Inturrisi | D-methadone and its derivatives for use in the treatment of disorders of the nervous system |
-
2019
- 2019-08-15 US US17/268,072 patent/US20210315865A1/en active Pending
- 2019-08-15 EP EP19849456.9A patent/EP3836922B1/en active Active
- 2019-08-15 CA CA3109769A patent/CA3109769A1/en active Pending
- 2019-08-15 AU AU2019322889A patent/AU2019322889A1/en not_active Abandoned
- 2019-08-15 MX MX2021001563A patent/MX2021001563A/es unknown
- 2019-08-15 WO PCT/US2019/046709 patent/WO2020037152A1/en not_active Ceased
- 2019-08-15 KR KR1020217007246A patent/KR20210045423A/ko not_active Ceased
- 2019-08-15 JP JP2021507740A patent/JP2021534160A/ja active Pending
- 2019-08-15 BR BR112021002692-4A patent/BR112021002692A2/pt not_active Application Discontinuation
- 2019-08-15 ES ES19849456T patent/ES2987802T3/es active Active
- 2019-08-15 SG SG11202100880VA patent/SG11202100880VA/en unknown
- 2019-08-15 CN CN201980054201.0A patent/CN112584831A/zh active Pending
- 2019-08-15 EA EA202190544A patent/EA202190544A1/ru unknown
-
2021
- 2021-01-28 PH PH12021550218A patent/PH12021550218A1/en unknown
- 2021-02-04 IL IL280657A patent/IL280657A/en unknown
- 2021-02-08 MX MX2024007642A patent/MX2024007642A/es unknown
-
2023
- 2023-10-19 JP JP2023179961A patent/JP2024010017A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534160A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2022520061A5 (https=) | ||
| ES2295009T3 (es) | Inhibidores de rho quinasa para la profilaxis y el tratamiento de neumonia intersticial y fibrosis pulmonar. | |
| JP2023002662A5 (https=) | ||
| JP2024133474A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2008501705A5 (https=) | ||
| JP5911929B2 (ja) | 特定の癌の治療のためのｒｄｅａ１１９／ｂａｙ８６９７６６を含む組み合わせ医薬 | |
| JP2006523216A5 (https=) | ||
| JP2022545005A5 (https=) | ||
| JP2009537550A5 (https=) | ||
| JP2019515884A5 (https=) | ||
| JP2010532768A5 (https=) | ||
| JP2021530543A5 (https=) | ||
| JP2006503850A5 (https=) | ||
| JP2022554276A5 (https=) | ||
| RU2018136580A (ru) | Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты | |
| JP2024520630A5 (https=) | ||
| JP2015517523A5 (https=) | ||
| JP2023055858A (ja) | ５′－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 | |
| JP2019533660A5 (https=) | ||
| JP2011502131A5 (https=) | ||
| JP2016537432A5 (https=) | ||
| JP2022169780A5 (https=) |